Transcription of Public Assessment Report Mutual Recognition …
{{id}} {{{paragraph}}}
PAR-APO-go PFS 5mg/ml Solution for Infusion in Pre- filled Syringe UK/H/0342/03/MR - 1 - Public Assessment Report Mutual Recognition Procedure APO-go PFS 5mg/ml Solution for infusion in pre- filled Syringe Apomorphine Hydrochloride UK/H/0342/03/MR Applicant: Forum Products Limited PAR-APO-go PFS 5mg/ml Solution for Infusion in Pre- filled Syringe UK/H/0342/03/MR - 2 - LAY SUMMARY The Medicines Healthcare products Regulatory Agency (MHRA) granted Forum Products Limited a Marketing Authorisation (national licence) for the medicinal product APO-go PFS 5mg/ml Solution for infusion in pre- filled Syringe on 15th September 2004. This is a prescription-only medicine (POM) used to treat Parkinson s disease. It helps to reduce the amount of time spent in an off or immobile state in people who have previously been treated for Parkinson s disease with levodopa and/or other dopamine agonists.
PAR-APO-go PFS 5mg/ml Solution for Infusion in Pre-Filled Syringe UK/H/0342/03/MR - 1 - Public Assessment Report Mutual Recognition Procedure
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}